1
|
Löwenberg B, Downing JR and Burnett A:
Acute myeloid leukemia. N Engl J Med. 341:1051–1062. 1999.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
3
|
Kaucká M, Plevová K, Pavlová S, Janovská
P, Mishra A, Verner J, Procházková J, Krejcí P, Kotasková J, Ovesná
P, et al: The planar cell polarity pathway drives pathogenesis of
chronic lymphocytic leukemia by the regulation of B-lymphocyte
migration. Cancer Res. 73:1491–1501. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Huelsken J, Vogel R, Brinkmann V, Erdmann
B, Birchmeier C and Birchmeier W: Requirement for beta-catenin in
anterior-posterior axis formation in mice. J Cell Biol.
148:567–578. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Giles RH, van Es JH and Clevers H: Caught
up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
6
|
Yu S, Zhou X, Steinke FC, Liu C, Chen SC,
Zagorodna O, Jing X, Yokota Y, Meyerholz DK, Mullighan CG, et al:
The TCF-1 and LEF-1 transcription factors have cooperative and
opposing roles in T cell development and malignancy. Immunity.
37:813–826. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Xu Y, Banerjee D, Huelsken J, Birchmeier W
and Sen JM: Deletion of beta-catenin impairs T cell development.
Nat Immunol. 4:1177–1182. 2003. View
Article : Google Scholar : PubMed/NCBI
|
8
|
Fusco C, Micale L, Augello B, Teresa
Pellico M, Menghini D, Alfieri P, Cristina Digilio M, Mandriani B,
Carella M, Palumbo O, et al: Smaller and larger deletions of the
Williams Beuren syndrome region implicate genes involved in mild
facial phenotype, epilepsy and autistic traits. Eur J Hum Genet.
22:64–70. 2014. View Article : Google Scholar
|
9
|
Laurito S, Branham T, Herrero G, Marsa S,
Garro F and Roqué M: Detection of a Williams Beuren syndrome case
by MLPA. Medicina (B Aires). 73:47–50. 2013.In Spanish.
|
10
|
Van Hagen JM, Eussen HJ, Van Schooten R,
van Der Geest JN, Lagers-van Haselen GC, Wouters CH, De Zeeuw CI
and Gille JJ: Comparing two diagnostic laboratory tests for
Williams syndrome: Fluorescent in situ hybridization versus
multiplex ligation-dependent probe amplification. Genet Test.
11:321–327. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kolben T, Peröbner I, Fernsebner K,
Lechner F, Geissler C, Ruiz-Heinrich L, Capovilla S, Jochum M and
Neth P: Dissecting the impact of Frizzled receptors in
Wnt/β-catenin signaling of human mesenchymal stem cells. Biol Chem.
393:1433–1447. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Reya T, Duncan AW, Ailles L, Domen J,
Scherer DC, Willert K, Hintz L, Nusse R and Weissman IL: A role for
Wnt signalling in self-renewal of haematopoietic stem cells.
Nature. 423:409–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Huelsken J, Vogel R, Erdmann B, Cotsarelis
G and Birchmeier W: beta-Catenin controls hair follicle
morphogenesis and stem cell differentiation in the skin. Cell.
105:533–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ranheim EA, Kwan HC, Reya T, Wang YK,
Weissman IL and Francke U: Frizzled 9 knock-out mice have abnormal
B-cell development. Blood. 105:2487–2494. 2005. View Article : Google Scholar
|
16
|
Jiang Y, Dunbar A, Gondek LP, Mohan S,
Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y and Maciejewski
JP: Aberrant DNA methylation is a dominant mechanism in MDS
progression to AML. Blood. 113:1315–1325. 2009. View Article : Google Scholar :
|
17
|
Tennis M, Van Scoyk M, Heasley LE,
Vandervest K, Weiser-Evans M, Freeman S, Keith RL, Simpson P,
Nemenoff RA and Winn RA: Prostacyclin Inhibits non-small cell lung
cancer growth by a frizzled 9-dependent pathway that is blocked by
secreted frizzled-related protein 1. Neoplasia. 12:244–253. 2010.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Winn RA, Van Scoyk M, Hammond M, Rodriguez
K, Crossno JT Jr, Heasley LE and Nemenoff RA: Antitumorigenic
effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is
mediated through ERK-5-dependent activation of peroxisome
proliferator-activated receptor gamma. J Biol Chem.
281:26943–26950. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Khan NI and Bendall LJ: Role of WNT
signaling in normal and malignant hematopoiesis. Histol
Histopathol. 21:761–774. 2006.PubMed/NCBI
|
20
|
Román-Gómez J, Cordeu L, Agirre X,
Jiménez-Velasco A, San José-Eneriz E, Garate L, Calasanz MJ,
Heiniger A, Torres A and Prosper F: Epigenetic regulation of
Wnt-signaling pathway in acute lymphoblastic leukemia. Blood.
109:3462–3469. 2007. View Article : Google Scholar
|
21
|
Liu TH, Raval A, Chen SS, Matkovic JJ,
Byrd JC and Plass C: CpG island methylation and expression of the
secreted frizzled-related protein gene family in chronic
lymphocytic leukemia. Cancer Res. 66:653–658. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Borssén M, Palmqvist L, Karrman K,
Abrahamsson J, Behrendtz M, Heldrup J, Forestier E, Roos G and
Degerman S: Promoter DNA methylation pattern identifies prognostic
subgroups in childhood T-cell acute lymphoblastic leukemia. PLoS
One. 8:e653732013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang Y, Li Q and Chen H: DNA methylation
and histone modifications of Wnt genes by genistein during colon
cancer development. Carcinogenesis. 34:1756–1763. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Portela A, Liz J, Nogales V, Setién F,
Villanueva A and Esteller M: DNA methylation determines nucleosome
occupancy in the 5′-CpG islands of tumor suppressor genes.
Oncogene. 32:5421–5428. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wodarz D, Boland CR, Goel A and Komarova
NL: Methylation kinetics and CpG-island methylator phenotyope
status in colorectal cancer cell lines. Biol Direct. 8:142013.
View Article : Google Scholar :
|
26
|
He W, Li X, Xu S, Ai J, Gong Y, Gregg JL,
Guan R, Qiu W, Xin D, Gingrich JR, et al: Aberrant methylation and
loss of CADM2 tumor suppressor expression is associated with human
renal cell carcinoma tumor progression. Biochem Biophys Res Commun.
435:526–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Twelves D, Nerurkar A, Osin P, Dexter T,
Ward A, Gui GP and Isacke CM: DNA promoter hypermethylation
profiles in breast duct fluid. Breast Cancer Res Treat.
139:341–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhang L, McHale CM, Rothman N, Li G, Ji Z,
Vermeulen R, Hubbard AE, Ren X, Shen M, Rappaport SM, et al:
Systems biology of human benzene exposure. Chem Biol Interact.
184:86–93. 2010. View Article : Google Scholar :
|
29
|
Lin X, Wang Z, Wang Y and Feng W: Serum
MicroRNA-370 as a potential diagnostic and prognostic biomarker for
pediatric acute myeloid leukemia. Int J Clin Exp Pathol.
8:14658–14666. 2015.
|
30
|
Koon HW, Shih DQ, Hing TC, Yoo JH, Ho S,
Chen X, Kelly CP, Targan SR and Pothoulakis C: Human monoclonal
antibodies against Clostridium difficile toxins A and B inhibit
inflammatory and histologic responses to the toxins in human colon
and peripheral blood monocytes. Antimicrob Agents Chemother.
57:3214–3223. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Xia L, Gong Y, Zhang A, Cai S and Zeng Q:
Loss of GATA5 expression due to gene promoter methylation induces
growth and colony formation of hepatocellular carcinoma cells.
Oncol Lett. 11:861–869. 2016.PubMed/NCBI
|
32
|
Li Y, Nagai H, Ohno T, Yuge M, Hatano S,
Ito E, Mori N, Saito H and Kinoshita T: Aberrant DNA methylation of
p57(KIP2) gene in the promoter region in lymphoid malignancies of
B-cell phenotype. Blood. 100:2572–2577. 2002. View Article : Google Scholar : PubMed/NCBI
|
33
|
Uchida T, Kinoshita T, Ohno T, Ohashi H,
Nagai H and Saito H: Hypermethylation of p16INK4A gene promoter
during the progression of plasma cell dyscrasia. Leukemia.
15:157–165. 2001. View Article : Google Scholar : PubMed/NCBI
|